ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.

Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J
פורמט: Journal article
שפה:English
יצא לאור: BMJ Publishing Group 2016